[Current treatment of the Parkinsonian syndrome].
D000547:Amantadine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000138:chemical synthesis; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use
D000928:Antidepressive Agents; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D002262:Carboxy-Lyases; D011736:Pyridoxine
Tratamentul actual al sindromului parkinsonian.